Showing 71 - 80 of 1,394
The premium rates paid for statutory health insurance in Germany play a key role in the competition among health care funds. With the most recent health care reform (GKV-Wettbewerbsstärkungsgesetz GKV-WSG), a range of new products have been introduced that could erode the advantageous selling...
Persistent link: https://www.econbiz.de/10010324278
Persistent link: https://www.econbiz.de/10014521960
Summary The premium rates paid for statutory health insurance in Germany play a key role in the competition among health care funds. With the most recent health care reform (GKV-Wettbewerbsstärkungsgesetz GKV-WSG), a range of new products have been introduced that could erode the advantageous...
Persistent link: https://www.econbiz.de/10014609158
Persistent link: https://www.econbiz.de/10005019153
It is currently intensively discussed whether the system of risk structure adjustment (RSA) among German statutory sickness funds should be supplemented by morbidity indicators. It has been showed that employees who change their sickness funds are better risks and thus shift the morbidity...
Persistent link: https://www.econbiz.de/10005068663
The premium rates paid for statutory health insurance in Germany play a key role in the competition among health care funds. With the most recent health care reform (GKV-Wettbewerbsstärkungsgesetz GKV-WSG), a range of new products have been introduced that could erode the advantageous selling...
Persistent link: https://www.econbiz.de/10010981008
The premium rates paid for statutory health insurance in Germany play a key role in the competition among health care funds. With the most recent health care reform (GKV-Wettbewerbsstaerkungsgesetz GKV-WSG), a range of new products have been introduced that could erode the advantageous selling...
Persistent link: https://www.econbiz.de/10008596471
Persistent link: https://www.econbiz.de/10005940758
Persistent link: https://www.econbiz.de/10005966402